Thienly Vo

Thienly Vo is a seasoned professional in Clinical Quality Assurance, currently serving as Sr. Director at Keros Therapeutics since December 2021. With a robust background that includes roles such as Director of Clinical Quality Assurance at Theravance Biopharma US, Inc. and Associate Director at Pharmacyclics, Thienly has honed expertise in regulatory quality assurance practices (RQAP-GCP). Prior experience also includes a Senior Manager position at Eisai and a Manager role at Iomai Corporation, as well as earlier work as Quality Specialist II at Baxter International Inc. Thienly Vo holds a Master of Science degree in Quality Assurance/Regulatory Affairs from Temple University.